Clinical Trials Directory

Trials / Sponsors / Axcella Health, Inc

Axcella Health, Inc

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedEfficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
Phase 22021-12-15
TerminatedEfficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy
Hepatic Encephalopathy
Phase 22021-06-29
UnknownSafety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
Non Alcoholic Steatohepatitis (NASH)
Phase 22021-05-07
CompletedTo Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With
To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease, Anemia, Sickle Cell, Sickle Cell Anemia
N/A2019-09-25
TerminatedStudy of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease
NAFLD
N/A2019-07-27
CompletedStudy of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
Hepatic Insufficiency
N/A2019-03-30
CompletedStudy of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease
NAFLD
N/A2018-12-03